| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/23/2007 | US7166623 Pain and inflammation |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166617 Cyclic amide derivatives |
| 01/23/2007 | US7166613 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands |
| 01/23/2007 | US7166608 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc. |
| 01/23/2007 | US7166605 Prophylaxis; endothelial diseases, oxidative stress, cardiovascular, inflammatory, cardiovascular, ocular, autoimmune diseases, neurological disorders and cancer, hypercholesterolemia and hyperlipidemia |
| 01/23/2007 | US7166597 Antiinflammatory agents; autoimmune disease treatments; pyrazolo(1,5-a)pyridine derivatives |
| 01/23/2007 | US7166592 Antiinflammatory agents |
| 01/23/2007 | US7166589 Quinoline derivatives |
| 01/23/2007 | US7166588 Derivatives and analogs of galanthamine |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166576 Methods for preserving organs and tissues |
| 01/23/2007 | US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 01/23/2007 | US7166293 Anticancer agents; antitumor agents; cardiovascular diosrders; antiinflammatory agents |
| 01/18/2007 | WO2007008154A1 Method for evaluating the effects of smoke on bronchioles |
| 01/18/2007 | WO2007007890A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
| 01/18/2007 | WO2007007886A1 An oxime derivative and preparations thereof |
| 01/18/2007 | WO2007007732A1 Agent for elevating adiponectin concentration |
| 01/18/2007 | WO2007007688A1 3,5-diamino-1,2,4-triazole derivative |
| 01/18/2007 | WO2007007665A1 Therapeutic agent for arteriosclerosis |
| 01/18/2007 | WO2007007588A1 Compound having cyclic group with planarity as core |
| 01/18/2007 | WO2007006751A2 Use of bpi protein for the treatment of disorders of the metabolism and cardiovascular disorders |
| 01/18/2007 | WO2007006688A1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 01/18/2007 | WO2007006547A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | WO2007006208A1 Medicinal composition containing ginseng secondary glycosides, its preparation method and application |
| 01/18/2007 | WO2007006203A1 A capsule formulation for treating hypertension and coronary heart disease and process for preparation thereof |
| 01/18/2007 | WO2006126081A3 Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors |
| 01/18/2007 | WO2006124713A3 4-biarylyl-1-phenylazetidin-2-ones |
| 01/18/2007 | WO2006122977A3 PROCESS FOR PREPARING 3α(β)-7α(β)-DIHYDROXY-6α(β)-ALKYL-5β-CHOLANIC ACID |
| 01/18/2007 | WO2006120552A3 ANHYDROUS CRYSTALLINE FORMS OF N-[1-(2-ETHOXYETHYL)-5-(N-ETHYL-N-METHYLAMINO)-7-(4-METHYLPYRIDIN-2-yl-AMINO)-1H-PYRAZOLO[4,3-d]PYRIMIDINE-3-CARBONYL]METHANESULFONAMIDE |
| 01/18/2007 | WO2006116349A3 Sustained release formulation and dosing schedules of leukotriene synthesis inhibitor for human therapy |
| 01/18/2007 | WO2006108008A3 A method and composition for nutritionally improving glucose control and insulin action |
| 01/18/2007 | WO2006107902A9 Use of spirostenols to treat mitochondrial disorders |
| 01/18/2007 | WO2006088748A3 Method for treating obesity |
| 01/18/2007 | WO2006055526A3 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 01/18/2007 | WO2006042104A3 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 01/18/2007 | US20070016074 Contact lens for collecting tears and detecting analytes for determining health status, ovulation detection, and diabetes screening |
| 01/18/2007 | US20070015816 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome |
| 01/18/2007 | US20070015797 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/18/2007 | US20070015775 Heterocyclic compounds |
| 01/18/2007 | US20070015769 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/18/2007 | US20070015766 Quinoline Derivatives as NK-3 and NK-2 Antagonists |
| 01/18/2007 | US20070015765 5-(2-pyrazinyl)-4methyl-1,2-dithiol-3-thione (Oltipraz) and its metabolites; neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis |
| 01/18/2007 | US20070015756 For therapy of hyperproliferative diseases |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015732 Adenosine receptor antagonists and methods of making and using the same |
| 01/18/2007 | US20070015730 [4-(tert-butyldimethylsilanyloxy)-3-oxobutyl]methylcarbamic acid tert-butyl ester; (R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-amine; for the treatment of cardiovascular disorders such as hypertension and chronic heart failure |
| 01/18/2007 | US20070014840 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
| 01/18/2007 | US20070014818 Liquid formulations with high concentration of human growth hormone (HGH) comprising 1,2-propylene glycol |
| 01/18/2007 | US20070014783 Use of collagenase to facilitate guide wire crossing in total arterial occlusions |
| 01/18/2007 | DE19782294B4 Nicht-Steroide Liganden für den Estrogenrezeptor Non-steroidal ligands for the estrogen receptor |
| 01/18/2007 | DE102006012263A1 Zusammensetzung zur Vermeidung und Behandlung kardiovaskulärer Störungen Composition for the prevention and treatment of cardiovascular disorders |
| 01/18/2007 | DE102005033099A1 Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung New 1,4-benzothiazepine-1,1-Dioxidderivat with improved properties, process for its preparation, pharmaceuticals comprising this compound and its use |
| 01/18/2007 | CA2615726A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 01/18/2007 | CA2614796A1 Cynara scolymus extracts, the use thereof and formulations containing them |
| 01/18/2007 | CA2614691A1 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 01/18/2007 | CA2614688A1 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
| 01/18/2007 | CA2609597A1 Method for evaluating the effects of smoke on bronchioles |
| 01/17/2007 | EP1743940A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/17/2007 | EP1743895A1 Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure |
| 01/17/2007 | EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives |
| 01/17/2007 | EP1743631A2 Use of an amphetamine composition for regulating memory consolidation |
| 01/17/2007 | EP1743630A2 Pharmaceutical combination |
| 01/17/2007 | EP1742950A1 Pyrazolo[4,3-d] pyrimidines |
| 01/17/2007 | EP1742945A1 Substituted phenylamino-pyrimidines |
| 01/17/2007 | EP1742938A1 Preparation of candesartan cilexetil in high purity |
| 01/17/2007 | EP1742932A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor |
| 01/17/2007 | EP1742663A2 Compositions capable of facilitating penetration across a biological barrier |
| 01/17/2007 | EP1719524A9 Nuclear transfer promoter for rac protein and method of screening the same |
| 01/17/2007 | EP1546369A4 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
| 01/17/2007 | EP1441667B1 Improved endoprosthetic device |
| 01/17/2007 | EP1400518B1 Heterocyclic compound derivatives and medicines |
| 01/17/2007 | EP1392309B1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/17/2007 | EP1345501B1 Nutritional and therapeutical preparations having antioxidant activity |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/17/2007 | EP1223977B1 Modified plant viruses and methods of use thereof |
| 01/17/2007 | EP1180518B1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 01/17/2007 | EP0954588B1 Ob fusion protein compositions and methods |
| 01/17/2007 | CN1898231A Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 01/17/2007 | CN1898203A Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 01/17/2007 | CN1898202A Anti-hypercholesterolemic compounds |
| 01/17/2007 | CN1898197A Novel compounds |
| 01/17/2007 | CN1897963A Use of cyclic anabaenopeptin-type peptides for the treatment of a condition wherein inhibition of carboxypeptidase u is beneficial, novel anabaenopeptin derivatives and intermediates thereof |
| 01/17/2007 | CN1897955A Glycerophospholipids containing omega-3 and omega-6 fatty acids |
| 01/17/2007 | CN1896267A Preparation of depressor peptide by silkworm chrysalis |
| 01/17/2007 | CN1896109A Alcohol-soluble Chinese-Angelica micromolecular polysaccharide, its preparation and use |
| 01/17/2007 | CN1896108A Preparation of specific anticoagulation matter and its use |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/17/2007 | CN1896096A Production of high-activity extrasin beta 4 derivative by gene engineering |
| 01/17/2007 | CN1896094A Angiotensin II receptors I immunogenic peptide section and its use |
| 01/17/2007 | CN1896088A C－芳基葡糖苷sglt2抑制剂 C- aryl glucoside sglt2 inhibitors |
| 01/17/2007 | CN1896078A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 01/17/2007 | CN1896076A Tricyclic-type compound, and medicine having it as effective component |
| 01/17/2007 | CN1896045A Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 01/17/2007 | CN1895673A The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 01/17/2007 | CN1895659A Chinese-medicinal preparation for treating hypertension and its making method |
| 01/17/2007 | CN1895649A Apoplexia electruary |
| 01/17/2007 | CN1895630A Chinese medicine for treating apoplexia hemiparalysis, chestache and cardiodynia and its preparation |
| 01/17/2007 | CN1895621A Medicine for treating cerebrovascular accident induced by high blood fat |